HEADER TRANSFERASE/TRANSFERASE INHIBITOR 10-NOV-21 7SSB TITLE CO-STRUCTURE OF PKG1 REGULATORY DOMAIN WITH COMPOUND 33 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CGMP-DEPENDENT PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CGK 1,CGK1,CGMP-DEPENDENT PROTEIN KINASE I,CGKI; COMPND 5 EC: 2.7.11.12; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PRKG1, PRKG1B, PRKGR1A, PRKGR1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BINDING SITES, CYCLIC AMP, CYCLIC GMP, CYCLIC GMP-DEPENDENT, PROTEIN KEYWDS 2 KINASE TYPE II, SIGNALING PROTEIN, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 3 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.O.FISCHMANN REVDAT 2 18-OCT-23 7SSB 1 REMARK REVDAT 1 24-AUG-22 7SSB 0 JRNL AUTH V.W.MAK,A.M.PATEL,R.YEN,J.HANISAK,Y.H.LIM,J.BAO,R.ZHENG, JRNL AUTH 2 W.M.SEGANISH,Y.YU,D.R.HEALY,A.OGAWA,Z.REN,A.SORIANO, JRNL AUTH 3 G.P.ERMAKOV,M.BEAUMONT,E.METWALLY,A.C.CHENG,A.VERRAS, JRNL AUTH 4 T.FISCHMANN,M.ZEBISCH,H.L.SILVESTRE,P.A.MCEWAN,J.BARKER, JRNL AUTH 5 P.REARDEN,T.J.GRESHOCK JRNL TITL OPTIMIZATION AND MECHANISTIC INVESTIGATIONS OF NOVEL JRNL TITL 2 ALLOSTERIC ACTIVATORS OF PKG1 ALPHA. JRNL REF J.MED.CHEM. V. 65 10318 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 35878399 JRNL DOI 10.1021/ACS.JMEDCHEM.1C02109 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.20 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 3 NUMBER OF REFLECTIONS : 27741 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.880 REMARK 3 FREE R VALUE TEST SET COUNT : 1076 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 14 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.45 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.16 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2868 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2071 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2770 REMARK 3 BIN R VALUE (WORKING SET) : 0.2063 REMARK 3 BIN FREE R VALUE : 0.2320 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.42 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 98 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 966 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 155 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 8.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.74 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.39600 REMARK 3 B22 (A**2) : -7.69610 REMARK 3 B33 (A**2) : 7.30000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.210 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.072 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.069 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.074 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.066 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.882 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.884 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2057 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3724 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 469 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 324 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2057 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 140 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2276 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.05 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.20 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 12.76 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7SSB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-NOV-21. REMARK 100 THE DEPOSITION ID IS D_1000260968. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-APR-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALBA REMARK 200 BEAMLINE : XALOC REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9792 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.31 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27749 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 28.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : 0.17000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.28500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5JAX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS 8.5 20 % V/V GLYCEROL REMARK 280 ETHOXYLATE, 3 % V/V POLYETHYLENEIMINE, PH 8.5, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 31.61100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 31.61100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 28.19700 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 40.32800 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 28.19700 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 40.32800 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 31.61100 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 28.19700 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 40.32800 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 31.61100 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 28.19700 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 40.32800 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 76 REMARK 465 ALA A 77 REMARK 465 HIS A 78 REMARK 465 HIS A 79 REMARK 465 HIS A 80 REMARK 465 HIS A 81 REMARK 465 HIS A 82 REMARK 465 HIS A 83 REMARK 465 HIS A 84 REMARK 465 HIS A 85 REMARK 465 GLU A 86 REMARK 465 ASN A 87 REMARK 465 LEU A 88 REMARK 465 TYR A 89 REMARK 465 PHE A 90 REMARK 465 GLN A 91 REMARK 465 SER A 92 REMARK 465 ARG A 93 REMARK 465 GLN A 94 REMARK 465 ALA A 95 REMARK 465 PHE A 96 REMARK 465 ARG A 97 REMARK 465 LYS A 98 REMARK 465 PHE A 99 REMARK 465 THR A 100 REMARK 465 LYS A 101 REMARK 465 SER A 102 REMARK 465 GLU A 103 REMARK 465 ARG A 104 REMARK 465 SER A 105 REMARK 465 LYS A 106 REMARK 465 ASP A 107 REMARK 465 LEU A 108 REMARK 465 ILE A 109 REMARK 465 LYS A 110 REMARK 465 GLU A 111 REMARK 465 ALA A 112 REMARK 465 ILE A 113 REMARK 465 LEU A 114 REMARK 465 ASP A 115 REMARK 465 ASN A 116 REMARK 465 ASP A 117 REMARK 465 PHE A 118 REMARK 465 MET A 119 REMARK 465 LYS A 120 REMARK 465 ASN A 121 REMARK 465 LEU A 122 REMARK 465 GLU A 123 REMARK 465 LEU A 124 REMARK 465 SER A 125 REMARK 465 GLN A 126 REMARK 465 ILE A 127 REMARK 465 GLN A 128 REMARK 465 GLU A 129 REMARK 465 ILE A 130 REMARK 465 VAL A 131 REMARK 465 ASP A 132 REMARK 465 CYS A 133 REMARK 465 MET A 134 REMARK 465 TYR A 135 REMARK 465 PRO A 136 REMARK 465 VAL A 137 REMARK 465 GLU A 138 REMARK 465 TYR A 139 REMARK 465 GLY A 140 REMARK 465 LYS A 141 REMARK 465 ASP A 142 REMARK 465 SER A 143 REMARK 465 CYS A 144 REMARK 465 ILE A 145 REMARK 465 ILE A 146 REMARK 465 LYS A 147 REMARK 465 GLU A 148 REMARK 465 GLY A 149 REMARK 465 ASP A 150 REMARK 465 VAL A 151 REMARK 465 GLY A 152 REMARK 465 SER A 153 REMARK 465 LEU A 154 REMARK 465 VAL A 155 REMARK 465 TYR A 156 REMARK 465 VAL A 157 REMARK 465 MET A 158 REMARK 465 GLU A 159 REMARK 465 ASP A 160 REMARK 465 GLY A 161 REMARK 465 LYS A 162 REMARK 465 VAL A 163 REMARK 465 GLU A 164 REMARK 465 VAL A 165 REMARK 465 THR A 166 REMARK 465 LYS A 167 REMARK 465 GLU A 168 REMARK 465 GLY A 169 REMARK 465 VAL A 170 REMARK 465 LYS A 171 REMARK 465 LEU A 172 REMARK 465 CYS A 173 REMARK 465 THR A 174 REMARK 465 MET A 175 REMARK 465 GLY A 176 REMARK 465 PRO A 177 REMARK 465 GLY A 178 REMARK 465 LYS A 179 REMARK 465 VAL A 180 REMARK 465 PHE A 181 REMARK 465 GLY A 182 REMARK 465 GLU A 183 REMARK 465 LEU A 184 REMARK 465 ALA A 185 REMARK 465 ILE A 186 REMARK 465 LEU A 187 REMARK 465 TYR A 188 REMARK 465 ASN A 189 REMARK 465 CYS A 190 REMARK 465 THR A 191 REMARK 465 ARG A 192 REMARK 465 THR A 193 REMARK 465 ALA A 194 REMARK 465 THR A 195 REMARK 465 VAL A 196 REMARK 465 LYS A 197 REMARK 465 THR A 198 REMARK 465 LEU A 199 REMARK 465 VAL A 200 REMARK 465 ASN A 201 REMARK 465 VAL A 202 REMARK 465 LYS A 203 REMARK 465 LEU A 204 REMARK 465 TRP A 205 REMARK 465 ALA A 206 REMARK 465 ILE A 207 REMARK 465 ASP A 208 REMARK 465 ARG A 209 REMARK 465 GLN A 210 REMARK 465 CYS A 211 REMARK 465 PHE A 212 REMARK 465 GLN A 213 REMARK 465 THR A 214 REMARK 465 ILE A 215 REMARK 465 MET A 216 REMARK 465 MET A 217 REMARK 465 PRO A 289 REMARK 465 SER A 290 REMARK 465 GLU A 291 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 324 -174.87 -179.38 REMARK 500 REMARK 500 REMARK: NULL DBREF 7SSB A 93 343 UNP Q13976 KGP1_HUMAN 78 328 SEQADV 7SSB MET A 76 UNP Q13976 INITIATING METHIONINE SEQADV 7SSB ALA A 77 UNP Q13976 EXPRESSION TAG SEQADV 7SSB HIS A 78 UNP Q13976 EXPRESSION TAG SEQADV 7SSB HIS A 79 UNP Q13976 EXPRESSION TAG SEQADV 7SSB HIS A 80 UNP Q13976 EXPRESSION TAG SEQADV 7SSB HIS A 81 UNP Q13976 EXPRESSION TAG SEQADV 7SSB HIS A 82 UNP Q13976 EXPRESSION TAG SEQADV 7SSB HIS A 83 UNP Q13976 EXPRESSION TAG SEQADV 7SSB HIS A 84 UNP Q13976 EXPRESSION TAG SEQADV 7SSB HIS A 85 UNP Q13976 EXPRESSION TAG SEQADV 7SSB GLU A 86 UNP Q13976 EXPRESSION TAG SEQADV 7SSB ASN A 87 UNP Q13976 EXPRESSION TAG SEQADV 7SSB LEU A 88 UNP Q13976 EXPRESSION TAG SEQADV 7SSB TYR A 89 UNP Q13976 EXPRESSION TAG SEQADV 7SSB PHE A 90 UNP Q13976 EXPRESSION TAG SEQADV 7SSB GLN A 91 UNP Q13976 EXPRESSION TAG SEQADV 7SSB SER A 92 UNP Q13976 EXPRESSION TAG SEQADV 7SSB SER A 218 UNP Q13976 ARG 203 ENGINEERED MUTATION SEQRES 1 A 268 MET ALA HIS HIS HIS HIS HIS HIS HIS HIS GLU ASN LEU SEQRES 2 A 268 TYR PHE GLN SER ARG GLN ALA PHE ARG LYS PHE THR LYS SEQRES 3 A 268 SER GLU ARG SER LYS ASP LEU ILE LYS GLU ALA ILE LEU SEQRES 4 A 268 ASP ASN ASP PHE MET LYS ASN LEU GLU LEU SER GLN ILE SEQRES 5 A 268 GLN GLU ILE VAL ASP CYS MET TYR PRO VAL GLU TYR GLY SEQRES 6 A 268 LYS ASP SER CYS ILE ILE LYS GLU GLY ASP VAL GLY SER SEQRES 7 A 268 LEU VAL TYR VAL MET GLU ASP GLY LYS VAL GLU VAL THR SEQRES 8 A 268 LYS GLU GLY VAL LYS LEU CYS THR MET GLY PRO GLY LYS SEQRES 9 A 268 VAL PHE GLY GLU LEU ALA ILE LEU TYR ASN CYS THR ARG SEQRES 10 A 268 THR ALA THR VAL LYS THR LEU VAL ASN VAL LYS LEU TRP SEQRES 11 A 268 ALA ILE ASP ARG GLN CYS PHE GLN THR ILE MET MET SER SEQRES 12 A 268 THR GLY LEU ILE LYS HIS THR GLU TYR MET GLU PHE LEU SEQRES 13 A 268 LYS SER VAL PRO THR PHE GLN SER LEU PRO GLU GLU ILE SEQRES 14 A 268 LEU SER LYS LEU ALA ASP VAL LEU GLU GLU THR HIS TYR SEQRES 15 A 268 GLU ASN GLY GLU TYR ILE ILE ARG GLN GLY ALA ARG GLY SEQRES 16 A 268 ASP THR PHE PHE ILE ILE SER LYS GLY THR VAL ASN VAL SEQRES 17 A 268 THR ARG GLU ASP SER PRO SER GLU ASP PRO VAL PHE LEU SEQRES 18 A 268 ARG THR LEU GLY LYS GLY ASP TRP PHE GLY GLU LYS ALA SEQRES 19 A 268 LEU GLN GLY GLU ASP VAL ARG THR ALA ASN VAL ILE ALA SEQRES 20 A 268 ALA GLU ALA VAL THR CYS LEU VAL ILE ASP ARG ASP SER SEQRES 21 A 268 PHE LYS HIS LEU ILE GLY GLY LEU HET B4I A9901 37 HETNAM B4I 4-({(2S,3S)-3-[(1S)-1-(3,5-DICHLOROPHENYL)-2- HETNAM 2 B4I HYDROXYETHOXY]-2-PHENYLPIPERIDIN-1-YL}METHYL)-3- HETNAM 3 B4I NITROBENZOIC ACID FORMUL 2 B4I C27 H26 CL2 N2 O6 FORMUL 3 HOH *155(H2 O) HELIX 1 AA1 SER A 218 SER A 233 1 16 HELIX 2 AA2 VAL A 234 SER A 239 1 6 HELIX 3 AA3 PRO A 241 LEU A 252 1 12 HELIX 4 AA4 GLY A 306 GLN A 311 5 6 HELIX 5 AA5 ARG A 333 GLY A 342 1 10 SHEET 1 AA1 4 GLU A 253 TYR A 257 0 SHEET 2 AA1 4 VAL A 326 ASP A 332 -1 O VAL A 330 N GLU A 253 SHEET 3 AA1 4 THR A 272 LYS A 278 -1 N ILE A 275 O LEU A 329 SHEET 4 AA1 4 TRP A 304 PHE A 305 -1 O PHE A 305 N PHE A 274 SHEET 1 AA2 4 TYR A 262 ILE A 264 0 SHEET 2 AA2 4 ASN A 319 ALA A 322 -1 O VAL A 320 N ILE A 263 SHEET 3 AA2 4 THR A 280 ARG A 285 -1 N ASN A 282 O ILE A 321 SHEET 4 AA2 4 VAL A 294 GLY A 300 -1 O ARG A 297 N VAL A 283 SHEET 1 AA3 2 ARG A 269 GLY A 270 0 SHEET 2 AA3 2 ASP A 314 VAL A 315 -1 O ASP A 314 N GLY A 270 CRYST1 56.394 80.656 63.222 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017732 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012398 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015817 0.00000